Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 431,000 | -224,000 | 380,000 | -68,000 | 258,000 |
| Other Working Capital | -671,000 | 2,827,000 | 132,000 | -1,160,000 | -539,000 |
| Other Operating Activity | 2,782,000 | 1,164,000 | 2,050,000 | 2,520,000 | 612,000 |
| Operating Cash Flow | $2,542,000 | $3,767,000 | $2,562,000 | $1,292,000 | $331,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -216,000 | -435,000 | -256,000 | -174,000 | -164,000 |
| Net Acquisitions | -70,000 | -33,000 | -34,000 | 337,000 | -85,000 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 18,000 |
| Purchase Sale Intangibles | -370,000 | 104,000 | -900,000 | -366,000 | 175,000 |
| Other Investing Activity | -2,928,000 | 286,000 | 112,000 | 74,000 | 336,000 |
| Investing Cash Flow | $-3,593,000 | $-361,000 | $-1,183,000 | $-185,000 | $-48,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -249,000 | -1,417,000 | -226,000 | -347,000 | -5,000 |
| Debt Issued | 9,205,000 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 12,000 | 1,000 | 1,000 | 4,000 | 15,000 |
| Dividend Paid | -952,000 | -951,000 | -951,000 | -1,151,000 | -946,000 |
| Other Financing Activity | -43,000 | -407,000 | -218,000 | -551,000 | -440,000 |
| Financing Cash Flow | $7,973,000 | $-2,774,000 | $-1,394,000 | $-2,045,000 | $-1,376,000 |
| Exchange Rate Effect | 12,000 | -8,000 | 13,000 | 1,000 | -35,000 |
| Beginning Cash Position | 3,817,000 | 3,194,000 | 3,196,000 | 4,134,000 | 5,262,000 |
| End Cash Position | 10,751,000 | 3,819,000 | 3,194,000 | 3,196,000 | 4,134,000 |
| Net Cash Flow | $6,922,000 | $632,000 | $-15,000 | $-938,000 | $-1,093,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,542,000 | 3,767,000 | 2,562,000 | 1,292,000 | 331,000 |
| Capital Expenditure | -601,000 | -632,000 | -1,284,000 | -661,000 | -354,000 |
| Free Cash Flow | 1,941,000 | 3,135,000 | 1,278,000 | 631,000 | -23,000 |